• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中文患者服用鲁拉西酮致皮疹:基于病例的回顾。

Rash caused by lurasidone in old chinese patient with bipolar disorder: case-based review.

机构信息

Department of Pharmacy, Tongde Hospital of ZheJiang Province, Hangzhou, Zhejiang, People's Republic of China.

Zhejiang Academy of Traditional Chinese Medicine, Hangzhou, Zhejiang, People's Republic of China.

出版信息

BMC Psychiatry. 2024 Jul 8;24(1):491. doi: 10.1186/s12888-024-05668-5.

DOI:10.1186/s12888-024-05668-5
PMID:38977949
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11229191/
Abstract

BACKGROUND

Rash is one of common adverse drug reaction and which have been reported in typical and atypical antipsychotics. Reports of lurasidone induced skin reactions are sparse. In this study, we report a case of rash caused by lurasidone.

CASE PRESENTATION

A 63-year-old man with bipolar disorder (BD) who is treated by lurasidone. However, the patient presents a rash all over after lurasidone dose increasing from 40 mg/day to 60 mg/day. With the diagnosis of drug induced rash, lurasidone was discontinued, and the rash complete disappears within 2 weeks. In addition, all case reports about antipsychotics associated rash were reviewed by searching English and Chinese database including Pubmed, Embase, Cochrane Library, CNKI and Wanfang database. A total of 139 articles contained 172 patients were included in our study. The literature review and our case suggest that the cutaneous adverse events caused by antipsychotic drugs should not be ignored, particularly for the patient who was first use or at dose increasing of antipsychotic.

CONCLUSIONS

In conclusion, we report a case of lurasidone related rash and review rash caused by antipsychotics. Psychiatrists should be alert to the possibility of the rash caused by antipsychotics, especially the patient was first use of antipsychotics or the antipsychotic dose was increasing.

摘要

背景

皮疹是一种常见的药物不良反应,在典型和非典型抗精神病药物中均有报道。关于鲁拉西酮引起皮肤反应的报告很少。在本研究中,我们报告了一例由鲁拉西酮引起的皮疹病例。

病例介绍

一名 63 岁男性,患有双相情感障碍(BD),接受鲁拉西酮治疗。然而,在鲁拉西酮剂量从 40mg/天增加到 60mg/天后,患者全身出现皮疹。诊断为药物引起的皮疹后,停用了鲁拉西酮,皮疹在 2 周内完全消失。此外,通过检索 Pubmed、Embase、Cochrane 图书馆、CNKI 和万方数据库,对所有关于抗精神病药相关皮疹的病例报告进行了综述,共纳入 139 篇文章,包含 172 例患者。文献回顾和我们的病例表明,抗精神病药物引起的皮肤不良反应不容忽视,特别是对于首次使用或增加抗精神病药物剂量的患者。

结论

总之,我们报告了一例鲁拉西酮相关皮疹病例,并对抗精神病药引起的皮疹进行了综述。精神科医生应警惕抗精神病药引起皮疹的可能性,尤其是患者首次使用抗精神病药或增加抗精神病药剂量时。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f1c/11229191/a4ebe1fe2ad0/12888_2024_5668_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f1c/11229191/a4ebe1fe2ad0/12888_2024_5668_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f1c/11229191/a4ebe1fe2ad0/12888_2024_5668_Fig1_HTML.jpg

相似文献

1
Rash caused by lurasidone in old chinese patient with bipolar disorder: case-based review.中文患者服用鲁拉西酮致皮疹:基于病例的回顾。
BMC Psychiatry. 2024 Jul 8;24(1):491. doi: 10.1186/s12888-024-05668-5.
2
Lurasidone versus typical antipsychotics for schizophrenia.鲁拉西酮与传统抗精神病药物治疗精神分裂症的比较。
Cochrane Database Syst Rev. 2025 Jan 20;1(1):CD012429. doi: 10.1002/14651858.CD012429.pub2.
3
Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.在精神分裂症和双相情感障碍的治疗中,阿塞那平、依匹哌酮、鲁拉西酮和帕利哌酮的体重和代谢不良影响:系统评价和探索性荟萃分析。
CNS Drugs. 2012 Sep 1;26(9):733-59. doi: 10.2165/11634500-000000000-00000.
4
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
5
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
6
Atypical antipsychotics for psychosis in adolescents.用于青少年精神病的非典型抗精神病药物。
Cochrane Database Syst Rev. 2013 Oct 15;2013(10):CD009582. doi: 10.1002/14651858.CD009582.pub2.
7
Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.非典型抗精神病药物超说明书使用的比较有效性评价综述
J Manag Care Pharm. 2012 Jun;18(5 Suppl B):S1-20. doi: 10.18553/jmcp.2012.18.S5-B.1.
8
Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.痴呆症老年人行为和心理症状的慢性抗精神病药物撤药与继续用药对比
Cochrane Database Syst Rev. 2013 Mar 28(3):CD007726. doi: 10.1002/14651858.CD007726.pub2.
9
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
10
Pharmacological interventions for those who have sexually offended or are at risk of offending.针对有性犯罪行为或有性犯罪风险者的药物干预措施。
Cochrane Database Syst Rev. 2015 Feb 18;2015(2):CD007989. doi: 10.1002/14651858.CD007989.pub2.

本文引用的文献

1
Potential Involvement of Sulfotransferase in the Mechanism of Lamotrigine-induced Skin Rash.磺基转移酶在拉莫三嗪引起皮疹机制中的潜在作用。
Chem Res Toxicol. 2023 Nov 20;36(11):1711-1716. doi: 10.1021/acs.chemrestox.3c00187. Epub 2023 Nov 3.
2
Patterns of pharmacotherapy for bipolar disorder: A GBC survey.双相情感障碍的药物治疗模式:一项全球生物制药公司(GBC)调查。
Bipolar Disord. 2024 Feb;26(1):22-32. doi: 10.1111/bdi.13366. Epub 2023 Jul 18.
3
Treating Bipolar Disorder Is Notoriously Difficult, but Research Underway Could Lead to New Options.
治疗双相情感障碍 notoriously 困难,但正在进行的研究可能会带来新的选择。
JAMA. 2023 Aug 1;330(5):395-398. doi: 10.1001/jama.2023.10057.
4
The Effect of Lurasidone on Anxiety Symptoms in Patients With Bipolar Depression: A Post Hoc Analysis.鲁拉西酮对双相抑郁患者焦虑症状的影响:一项事后分析。
J Clin Psychiatry. 2023 Jun 7;84(4):22m14732. doi: 10.4088/JCP.22m14732.
5
The efficacy and safety of lurasidone in bipolar I depression with and without rapid cycling: A pooled post-hoc analysis of two randomized, placebo-controlled trials.在伴有或不伴有快速循环的双相 I 型抑郁中,鲁拉西酮的疗效和安全性:两项随机、安慰剂对照试验的事后 pooled 分析。
J Affect Disord. 2023 Sep 15;337:150-158. doi: 10.1016/j.jad.2023.05.065. Epub 2023 May 26.
6
Mood Stabilizers of First and Second Generation.第一代和第二代心境稳定剂。
Brain Sci. 2023 Apr 29;13(5):741. doi: 10.3390/brainsci13050741.
7
Lurasidone for Treating Schizophrenia and Bipolar Depression: A Review of Its Efficacy.鲁拉西酮治疗精神分裂症和双相抑郁:疗效综述
Cureus. 2023 Apr 24;15(4):e38071. doi: 10.7759/cureus.38071. eCollection 2023 Apr.
8
Clinical use of mood stabilizers beyond treatment for bipolar disorder: The REAP-MS study.心境稳定剂在双相障碍治疗以外的临床应用:REAP-MS 研究。
Asian J Psychiatr. 2023 Jul;85:103613. doi: 10.1016/j.ajp.2023.103613. Epub 2023 Apr 28.
9
Lurasidone in first-episode psychosis with predominant depressive symptoms: a case report.伴有主要抑郁症状的首发精神病患者使用鲁拉西酮:一例病例报告。
Int Clin Psychopharmacol. 2023 Jul 1;38(4):275-280. doi: 10.1097/YIC.0000000000000465. Epub 2023 Feb 27.
10
Fire and Darkness: On the Assessment and Management of Bipolar Disorder.《火与黑暗:双相情感障碍的评估与管理》
Med Clin North Am. 2023 Jan;107(1):31-60. doi: 10.1016/j.mcna.2022.04.002. Epub 2022 Oct 28.